Laibson P R, Arentsen J J, Mazzanti W D, Eiferman R A
Trans Am Ophthalmol Soc. 1977;75:316-24.
Thirty-three patients were followed in a double controlled study to test the efficacy of IDU and TFT on superficial epithelial herpes simplex virus infection. Sixteen received TFT and 17, IDU. There were four failures in patients on IDU therapy and no failures in the 16 patients using TFT. These results indicate a trend for greater efficacy of TFT than IDU. In those patients who healed with IDU and with TFT, there was no difference in the number of days to heal in each group.
在一项双对照研究中对33名患者进行了跟踪,以测试碘苷(IDU)和三氟胸腺嘧啶核苷(TFT)对浅表上皮单纯疱疹病毒感染的疗效。16名患者接受了TFT治疗,17名患者接受了IDU治疗。接受IDU治疗的患者中有4例治疗失败,而使用TFT的16名患者中没有失败病例。这些结果表明TFT比IDU有更高疗效的趋势。在那些使用IDU和TFT治愈的患者中,每组的治愈天数没有差异。